Abstract
Human beings possess a considerable reserve capacity that allows them to benefit from exposure to highly enriched environments. The hypothesis of environmental complexity states that those individuals involved in activities that require greater cognitive demands keep their cognitive abilities undamaged despite the passing of time. The aim of this review is to present an analysis of the results obtained from empirical research made between 1980 and 2014 in Europe and America, focusing on the impact that cognitive reserve has on older adults.
This review will demonstrate how environmental complexity and the importance of engaging in recreational activities influence individuals’ lives and their cognitive healthy aging. Bibliography was obtained systematically, through a defined search strategy of several data bases. Ninety one scientific articles were selected in agreement with the appropriateness they keep with the objective of the present research.
In regard to pharmacological treatment, there is little evidence that cholinesterase inhibitor drugs affect progression to dementia or improve cognitive performance of patients with MCI. Complementarily, mixed results have been reported from different research lines that use cognitive training. Besides, there is increasing evidence that consider the role of environment and lifestyle as protective factors for the development of Alzheimer’s disease from MCI. The review sheds some suggestions for future research related to the studied topics and for professional intervention in the area of gerontology.
Keywords: Activity theory, cognitive functioning, environmental complexity, leisure activities, professional intervention, work complexity.
Current Psychopharmacology
Title:Occupational Complexity and Leisure Activities in Cognitive Aging
Volume: 3
Author(s): Carolina Feldberg, Dorina Stefani and Ricardo Francisco Allegri
Affiliation:
Keywords: Activity theory, cognitive functioning, environmental complexity, leisure activities, professional intervention, work complexity.
Abstract: Human beings possess a considerable reserve capacity that allows them to benefit from exposure to highly enriched environments. The hypothesis of environmental complexity states that those individuals involved in activities that require greater cognitive demands keep their cognitive abilities undamaged despite the passing of time. The aim of this review is to present an analysis of the results obtained from empirical research made between 1980 and 2014 in Europe and America, focusing on the impact that cognitive reserve has on older adults.
This review will demonstrate how environmental complexity and the importance of engaging in recreational activities influence individuals’ lives and their cognitive healthy aging. Bibliography was obtained systematically, through a defined search strategy of several data bases. Ninety one scientific articles were selected in agreement with the appropriateness they keep with the objective of the present research.
In regard to pharmacological treatment, there is little evidence that cholinesterase inhibitor drugs affect progression to dementia or improve cognitive performance of patients with MCI. Complementarily, mixed results have been reported from different research lines that use cognitive training. Besides, there is increasing evidence that consider the role of environment and lifestyle as protective factors for the development of Alzheimer’s disease from MCI. The review sheds some suggestions for future research related to the studied topics and for professional intervention in the area of gerontology.
Export Options
About this article
Cite this article as:
Feldberg Carolina, Stefani Dorina and Allegri Francisco Ricardo, Occupational Complexity and Leisure Activities in Cognitive Aging, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140717183716
DOI https://dx.doi.org/10.2174/2211556003666140717183716 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
Neuromodulation for the treatment of psychiatric disorders
Neuromodulation techniques, including transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), magnetic seizure therapy (MST), electroconvulsive therapy (ECT), theta burst stimulation (TBS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS), have been widely employed in the therapeutic management of prevalent psychiatric conditions such ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuronal and Glial Responses to Polyamines in the Ischemic Brain
Current Neurovascular Research Adenosine Receptors in Modulation of Central Nervous System Disorders
Current Pharmaceutical Design One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study
Current Alzheimer Research Efficacy of Vitamins B Supplementation on Mild Cognitive Impairment and Alzheimer`s Disease: A Systematic Review and Meta-Analysis
Current Alzheimer Research Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Carbon Monoxide-Releasing Molecules: A Pharmacological Expedient to Counteract Inflammation
Current Pharmaceutical Design Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System
Current Drug Targets - Cardiovascular & Hematological Disorders Classic β-Amyloid Deposits Cluster Around Large Diameter Blood Vessels Rather than Capillaries in Sporadic Alzheimers Disease
Current Neurovascular Research Discovery of Neurogenic, Alzheimers Disease Therapeutics
Current Alzheimer Research Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders
Current Protein & Peptide Science Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)]
Current Pharmaceutical Design Non-Globular Structures of Tandem Repeats in Proteins
Protein & Peptide Letters Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) High Fat Meal Increase of IL-17 is Prevented by Ingestion of Fruit Juice Drink in Healthy Overweight Subjects
Current Pharmaceutical Design Drugs of Abuse and Oxidative Stress in the Brain: From Animal Models to Human Evidence
Mini-Reviews in Organic Chemistry Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases
CNS & Neurological Disorders - Drug Targets Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Current Traditional Medicine Confocal Microscopy Evidence of Prion Protein Fragment hPrP[173-195] Internalization in Rat B104 Neuroblastoma Cell Line
Protein & Peptide Letters Electroporation Gene Therapy: New Developments In Vivo and In Vitro
Current Gene Therapy